KEI Letter to NIH regarding UPenn/ James Wilson et al. Failure to Disclose Federal Funding in 7 patents relating to gene therapy
On September 3, 2019, KEI submitted a request to the NIH that it investigate an apparent failure to disclose federal funding in patents in adeno-associated viral (AAV) gene therapies. A failure to disclose federal funding is a violation of the… Continue Reading